drugset / Trial / NCT02420015
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is designed to evaluate if a treatment the investigators call iCOMMIT is effective at helping smokers with schizophrenia stop smoking. iCOMMIT is a smoking cessation treatment that combines mobile technology with behavioral strategies, counseling, and medications.
Timeline
- Start
- 2017-03-27
- Primary completion
- 2019-01-24
- Completion
- 2019-01-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Bupropion | Small molecule | 300 mg | — |
| Background | Nicotine | Unknown | — | Topical |